top of page
Home
Calvine Healthcare
Calvine Sustainables
Equity Research
Basilea
Blog
Contact
Â
Use tab to navigate through the menu items.
All Posts
Search
Graeme Kyle
5 days ago
Breedon - on course for net zero
Graeme Kyle
Nov 7
Volution - investing for climate action
Brian White
Nov 4
Basilea - Another significant milestone
Andrew Keith
Sep 25
Basilea - Infectious growth
Brian White
Sep 16
Basilea - Further BARDA payments
Andrew Keith
Aug 19
Basilea - Another strong H1
Brian White
Aug 14
Basilea - a new Phase 3-ready antibiotic
Andrew Keith
Jul 29
Basilea - Pivotal Phase 3 trial begins
Brian White
Jul 8
Basilea - More non-dilutive funding
Brian White
Jun 5
Cresemba's sales momentum continues
Brian White
May 20
Zevtera launches in the US
Andrew Keith
Apr 28
Basilea - Going for growth
Brian White
Feb 18
Another year of strong execution
Andrew Keith
Feb 5
Basilea - Cresemba's new high
Brian White
Jan 28
Basilea - A breadth of demand
Brian White
Jan 8
Basilea - Infectious success
Brian White
Dec 23, 2024
Basilea - Non-dilutive antibiotic funding
Brian White
Dec 16, 2024
Basilea - Ceftobiprole partner secured
Andrew Keith
Nov 18, 2024
PureTech Health - Patient Capital?
Andrew Keith
Oct 23, 2024
Basilea - A Perfect Match
bottom of page
